Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $8.10 million. The enterprise value is $4.81 million.

Market Cap	8.10M
Enterprise Value	4.81M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Genprex has 3.60 million shares outstanding. The number of shares has increased by 36.05% in one year.

Shares Outstanding	3.60M
Shares Change (YoY)	+36.05%
Shares Change (QoQ)	+33.60%
Owned by Insiders (%)	0.27%
Owned by Institutions (%)	5.15%
Float	3.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.19
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.95

Current Ratio	1.95
Quick Ratio	1.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -318.88% and return on invested capital (ROIC) is -200.41%.

Return on Equity (ROE)	-318.88%
Return on Assets (ROA)	-145.94%
Return on Capital (ROIC)	-200.41%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.43% in the last 52 weeks. The beta is -0.60, so Genprex's price volatility has been lower than the market average.

Beta (5Y)	-0.60
52-Week Price Change	-72.43%
50-Day Moving Average	0.79
200-Day Moving Average	2.58
Relative Strength Index (RSI)	60.52
Average Volume (20 Days)	27,262,214

Short Selling Information

The latest short interest is 85,218, so 2.37% of the outstanding shares have been sold short.

Short Interest	85,218
Short Previous Month	81,020
Short % of Shares Out	2.37%
Short % of Float	2.53%
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.29M
Pretax Income	-27.63M
Net Income	-26.14M
EBITDA	-26.28M
EBIT	-26.29M
Earnings Per Share (EPS)	-$15.57

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	2.46M
Total Debt	n/a
Net Cash	2.46M
Net Cash Per Share	$0.68
Equity (Book Value)	4.35M
Book Value Per Share	1.70
Working Capital	2.14M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.79M
Capital Expenditures	n/a
Free Cash Flow	-20.79M
FCF Per Share	-$5.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.05%
Shareholder Yield	-36.05%
Earnings Yield	-359.64%
FCF Yield	-286.05%

Analyst Forecast

The average price target for Genprex is $10.00, which is 344.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	344.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	0.025:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1